De Caterina R - Search Results

1

Ranolazine in the prevention of anthracycline cardiotoxicity.

Corradi F, Paolini L, De Caterina R. Corradi F, et al. Among authors: de caterina r. Pharmacol Res. 2014 Jan;79:88-102. doi: 10.1016/j.phrs.2013.11.001. Epub 2013 Nov 21. Pharmacol Res. 2014. PMID: 24269342 Review.

2

[Ranolazine in the prevention of anthracycline-related cardiotoxicity].

Corradi F, Paolini L, De Caterina R. Corradi F, et al. Among authors: de caterina r. G Ital Cardiol (Rome). 2013 Jun;14(6):424-37. doi: 10.1714/1280.14156. G Ital Cardiol (Rome). 2013. PMID: 23748539 Review. Italian.

3

Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.

Massaro M, Scoditti E, Pellegrino M, Carluccio MA, Calabriso N, Wabitsch M, Storelli C, Wright M, De Caterina R. Massaro M, et al. Among authors: de caterina r. Pharmacol Res. 2016 May;107:125-136. doi: 10.1016/j.phrs.2016.02.027. Epub 2016 Mar 11. Pharmacol Res. 2016. PMID: 26976796

4

[Iron and stable ischemic heart disease - lessons from heart failure].

Corradi F, Fischetti I, De Caterina R. Corradi F, et al. Among authors: de caterina r. G Ital Cardiol (Rome). 2019 Oct;20(10):559-573. doi: 10.1714/3228.32055. G Ital Cardiol (Rome). 2019. PMID: 31593159 Review. Italian.

5

Addenda online<br> Ferro e cardiopatia ischemica stabile - lezioni dallo scompenso cardiaco.

Corradi F, Fischetti I, De Caterina R. Corradi F, et al. Among authors: de caterina r. G Ital Cardiol (Rome). 2019 Oct;20(10):0. doi: 10.1714/3228.32062. G Ital Cardiol (Rome). 2019. PMID: 31593160 Italian. No abstract available.

6

Iron deficiency in myocardial ischaemia: molecular mechanisms and therapeutic perspectives.

Corradi F, Masini G, Bucciarelli T, De Caterina R. Corradi F, et al. Among authors: de caterina r. Cardiovasc Res. 2023 Nov 15;119(14):2405-2420. doi: 10.1093/cvr/cvad146. Cardiovasc Res. 2023. PMID: 37722377

7

Vasoactive eicosanoids in the rat heart: clues to a contributory role of cardiac thromboxane to post-ischaemic hyperaemia.

Giannessi D, Lazzerini G, Sicari R, DeCaterina R. Giannessi D, et al. Pharmacol Res. 1992 Dec;26(4):341-56. doi: 10.1016/1043-6618(92)90233-2. Pharmacol Res. 1992. PMID: 1294940

8

Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man.

Giannessi D, Lazzerini G, Filipponi P, Mannarelli C, Vaiani G, Grossi E, De Caterina R. Giannessi D, et al. Among authors: de caterina r. Pharmacol Res. 1993 Oct-Nov;28(3):229-41. doi: 10.1006/phrs.1993.1126. Pharmacol Res. 1993. PMID: 8108313

9

Cellular effects of thrombin: pharmacology of the receptor(s) in various cell types and possible development of receptor antagonists.

De Caterina R, Sicari R. De Caterina R, et al. Pharmacol Res. 1993 Jan-Feb;27(1):1-19. doi: 10.1006/phrs.1993.1001. Pharmacol Res. 1993. PMID: 8384364 Review.

10

Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks.

De Caterina R. De Caterina R. Ital Heart J. 2003 Apr;4(4):228-31. Ital Heart J. 2003. PMID: 12784774 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

834 results

Search Page